Experienced in Hemorrhagic Proctocolitis

Dr. Gil Fernandez-Yera

General Practice
3971 Sw 8 Street, Suite 201, 
Miami, FL 
Experienced in Hemorrhagic Proctocolitis
3971 Sw 8 Street, Suite 201, 
Miami, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Gil Fernandez-Yera is a primary care provider, practicing in General Practice in Miami, Florida. Dr. Fernandez-Yera is rated as an Experienced provider by MediFind in the treatment of Hemorrhagic Proctocolitis. His top areas of expertise are Viral Gastroenteritis, Crohn's Disease, Ulcerative Colitis, and Hemorrhagic Proctocolitis.

His clinical research consists of participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 3 clinical trials in the study of Hemorrhagic Proctocolitis.

Specialties
General Practice
Licenses
General Practice in FL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

3971 Sw 8 Street, Suite 201, Miami, FL 33134

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized , Double Blind, Placebo Controlled, 3-Arm Parallel Design Study to Evaluate the Effects of BPN14770 in Patients With Early Stage Alzheimer's Disease
A Randomized , Double Blind, Placebo Controlled, 3-Arm Parallel Design Study to Evaluate the Effects of BPN14770 in Patients With Early Stage Alzheimer's Disease
Enrollment Status: Completed
Publish Date: February 18, 2025
Intervention Type: Drug
Study Drug: BPN14770
Study Phase: Phase 2
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug, Other
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
Enrollment Status: Terminated
Publish Date: June 14, 2021
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 305)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 305)
Enrollment Status: Terminated
Publish Date: April 29, 2021
Intervention Type: Other, Biological
Study Phase: Phase 3
View 5 Less Clinical Trials
Similar Doctors
Advanced in Hemorrhagic Proctocolitis
Dr. Freddy J. Caldera
General Practice
Advanced in Hemorrhagic Proctocolitis
Dr. Freddy J. Caldera
General Practice
480 Minola Dr, 
Miami Springs, FL 
 (3.4 miles away)
305-649-6111
Languages Spoken:
English
See accepted insurances

Freddy Caldera is a primary care provider, practicing in General Practice in Miami Springs, Florida. Dr. Caldera is rated as a Distinguished provider by MediFind in the treatment of Hemorrhagic Proctocolitis. His top areas of expertise are Shingles, Viral Gastroenteritis, Chickenpox, Colonoscopy, and Endoscopy.

Experienced in Hemorrhagic Proctocolitis
Dr. Susana T. Ferra
General Practice
Experienced in Hemorrhagic Proctocolitis
Dr. Susana T. Ferra
General Practice

Integrated Regional Laboratories Pathology Services, LLC

5301 S Congress Ave, 
Atlantis, FL 
 (58.6 miles away)
561-548-3639
Languages Spoken:
English

Susana Ferra is a primary care provider, practicing in General Practice in Atlantis, Florida. Dr. Ferra is rated as a Distinguished provider by MediFind in the treatment of Hemorrhagic Proctocolitis. Her top areas of expertise are Sepsis, Anemia, Peptic Ulcer, Necrosis, and Tubal Ligation.

Experienced in Hemorrhagic Proctocolitis
Dr. Angel E. Rico
Family Medicine | General Practice | Pediatrics
Experienced in Hemorrhagic Proctocolitis
Dr. Angel E. Rico
Family Medicine | General Practice | Pediatrics
15495 Eagle Nest Lane, Suite 225, 
Miami Lakes, FL 
 (10.7 miles away)
305-828-3214
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Angel Rico is a primary care provider, practicing in Family Medicine and General Practice in Miami Lakes, Florida. Dr. Rico is rated as an Experienced provider by MediFind in the treatment of Hemorrhagic Proctocolitis. His top areas of expertise are Viral Gastroenteritis, Crohn's Disease, Ulcerative Colitis, and Hemorrhagic Proctocolitis. Dr. Rico is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Fernandez-Yera's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile